T26 (Carbamazepine extended-release 200 mg)
Pill imprint T26 has been identified as Carbamazepine extended-release 200 mg.
Carbamazepine is used in the treatment of bipolar disorder; trigeminal neuralgia; schizoaffective disorder; epilepsy; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- T26
- Strength:
- 200 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Taro Pharmaceutical Industries Ltd.
- National Drug Code (NDC):
- 51672-4124
- Inactive Ingredients:
- corn starch
diethyl phthalate
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
| NDC Code | Manufacturer / Repackager |
|---|---|
| 60429-0937 | Golden State Medical Supply (repackager) |
Note: Inactive ingredients may vary.
More about carbamazepine
Consumer resources
- Carbamazepine
- Carbamazepine chewable tablets
- Carbamazepine suspension
- Carbamazepine sustained-release capsules
- Carbamazepine sustained-release tablets
- Carbamazepine (Advanced Reading)
- Other brands: Tegretol, Carbatrol, Epitol, Tegretol XR, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
